
Dermagnostix was founded as a spin-off from the Hahn-Schickard Institute in Freiburg, the Helmholtz Zentrum München (HMGU), and TU Munich. Built on decades of world-class research in dermatology, immunology, bioinformatics, and microfluidics, our company combines scientific excellence with practical application. Today, we are headquartered in Freiburg, Southern Germany, a region known for innovation in medical technology.
While modern therapies for inflammatory skin diseases and skin cancer have advanced rapidly, diagnostics have lagged behind. Dermagnostix closes this gap by bringing objective molecular results directly into dermatology practices and laboratories.
